Disrupting the expression of the minor spliceosome component RNPC3 reduces the growth of oncogene-driven cancer cells in a broad spectrum of tumours. Targeting the minor spliceosome may provide an ...

Many cancer survivors struggle with muscle weakness, which can be so profound that they may have difficulties walking up a ...

Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...

A collaborative research team has successfully developed a novel fluorescent probe, SLY (Sialyl Lewis Yellow), capable of ...

A University of Minnesota Medical School-led research team has discovered that a cancer signaling pathway has previously ...

The discovery may explain why cutting edge CAR T-cell therapy has managed to revolutionized treatment for blood cancer but ...

One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.

In the realm of cancer biology, the intersection of aging and cancer presents unique challenges, characterized by tumor ...

Post-translational modifications (PTMs) are essential players in regulating protein functions, including stability, localization, and interactions, and they ...